A pilot study of plasma metabolomic patterns from patients treated with ketamine for bipolar depression: evidence for a response-related difference in mitochondrial networks

Rapid antidepressant effects of ketamine ignite drug discovery

(2013) Elie Dolgin   NATURE MEDICINE

Relationship of Ketamine's Plasma Metabolites with Response, Diagnosis, and Side Effects in Major Depression

(2012) Carlos A. Zarate et al.   BIOLOGICAL PSYCHIATRY

Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression

(2012) Xiaochen Zhao et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Dysregulated Mitochondrial Genes and Networks with Drug Targets in Postmortem Brain of Patients with Posttraumatic Stress Disorder (PTSD) Revealed by Human Mitochondria-Focused cDNA Microarrays

(2012) Yan A. Su et al.   International Journal of Biological Sciences

Merging pharmacometabolomics with pharmacogenomics using ‘1000 Genomes’ single-nucleotide polymorphism imputation

(2012) Ryan Abo et al.   Pharmacogenetics and Genomics

Metabolomics with LC-QTOF-MS Permits the Prediction of Disease Stage in Aortic Abdominal Aneurysm Based on Plasma Metabolic Fingerprint

(2012) Michal Ciborowski et al.   PLoS One

In vitro inhibition of mitochondrial respiratory rate by antidepressants

(2012) Jana Hroudová et al.   TOXICOLOGY LETTERS

Cerebrospinal Fluid Metabolome in Mood Disorders-Remission State has a Unique Metabolic Profile

(2012) Rima Kaddurah-Daouk et al.   Scientific Reports

Antidepressant-like effect of artemin in mice: a mechanism for acetyl-l-carnitine activity on depression

(2011) Lorenzo Di Cesare Mannelli et al.   PSYCHOPHARMACOLOGY

Direct infusion mass spectrometry or liquid chromatography mass spectrometry for human metabonomics? A serum metabonomic study of kidney cancer

(2010) Lin Lin et al.   ANALYST

A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression

(2010) Nancy Diazgranados et al.   ARCHIVES OF GENERAL PSYCHIATRY

Glycine and a Glycine Dehydrogenase (GLDC) SNP as Citalopram/Escitalopram Response Biomarkers in Depression: Pharmacometabolomics-Informed Pharmacogenomics

(2010) Y Ji et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Metabolomic Differences in Heart Failure Patients With and Without Major Depression

(2010) David C. Steffens et al.   JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY

Carnitine in the treatment of valproic acid-induced toxicity

(2009) Philippe E.R. Lheureux et al.   CLINICAL TOXICOLOGY

Rapid Onset of Antidepressant Action

(2009) Rodrigo Machado-Vieira et al.   JOURNAL OF CLINICAL PSYCHIATRY

Metabolomics tools for identifying biomarkers for neuropsychiatric diseases

(2009) Marlon P. Quinones et al.   NEUROBIOLOGY OF DISEASE

Metabolomics: A Global Biochemical Approach to Drug Response and Disease

(2008) Rima Kaddurah-Daouk et al.   Annual Review of Pharmacology and Toxicology

The utility of biomarker discovery approaches for the detection of disease mechanisms in psychiatric disorders

(2008) E Schwarz et al.   BRITISH JOURNAL OF PHARMACOLOGY

Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: A review

(2008) M. F. B. Silva et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder

(2008) M J Lan et al.   MOLECULAR PSYCHIATRY

Metabolomics: A Global Biochemical Approach to the Study of Central Nervous System Diseases

(2008) Rima Kaddurah-Daouk et al.   NEUROPSYCHOPHARMACOLOGY